Company Overview and News


Add ABBOTINDIA
to your dashboard

Headline News

Abbott India shares surge over 12% on Q2 profit

2017-11-13 moneycontrol
Shares of drug firm Abbott India on Monday soared over 12 percent after the company reported 83.31 percent jump in net profit for the September quarter.

Closing Bell: Selling pressure grips Sensex as it ends 281 pts lower; Nifty below 10,250

2017-11-13 moneycontrol
3:30 pm Market at Close: Selling pressure in the final hour of trade dragged the market lower, with the Sensex closing over 250 points lower, while the Nifty closed below 10,250-mark. (32-0)

Abbott India Q2 profit rises 83% to Rs137.52 crore

2017-11-13 livemint
New Delhi: Drug firm Abbott India on Monday reported 83.31% jump in net profit to Rs137.52 crore for the September quarter on account of robust sales.

Abbott India Q2 net surges 83% at Rs 138 cr on robust sales

2017-11-13 business-standard
Drug firm Abbott India today reported 83.31 per cent jump in net profit to Rs 137.52 crore for the September quarter on account of robust sales. It had posted a net profit of Rs 75.02 crore for the corresponding period of last fiscal, Abbott India said in a filing to BSE.

Vakrangee, Abbott India hit 52-week highs on strong Q2 numbers

2017-11-13 moneycontrol
Shares of Vakrangee and Abbott India touched their 52- week highs, gaining 5 percent and 20 percent respectively on the back of strong Q2 numbers.

Torrent Pharma in advanced talks to buy Unichem’s India business for Rs3,200-3,300 crore

2017-10-30 livemint
Mumbai: Torrent Pharmaceuticals Ltd is likely in advanced discussions to acquire the domestic formulations business of Unichem Laboratories Ltd for Rs3,200-3,300 crore, two people aware of the development said on the condition of anonymity. (36-0)

Indian ADRs end higher; ICICI Bank, Infosys slip

2017-10-23 indiainfoline
Indian ADRs ended on a positive note reflecting a positive trade in the US markets. Dr. Reddy's Laboratories, Azure Power, HDFC Bank, Tata Motors, Vedanta, Wipro, WNS (Holdings) and Yatra Online were among the gainers. (16-0)

Opening Bell - Markets open higher

2017-10-04 indiainfoline
Nifty opened at 9,884 level, up by 25 points while Sensex opened at 31,522 level, up by 25 points.

Abbott India Q1 profit down 35% at Rs48 crore

2017-08-08 livemint
New Delhi: Pharmaceuticals firm Abbott India on Tuesday reported 34.8% decline in net profit to Rs48.25 crore for the first quarter ended 30 June, with sales hit by de-stocking in trade channels ahead of the goods and services tax (GST) implementation.

Abbott India Q1 net profit down 35% at Rs 48 cr

2017-08-08 thehindubusinessline
Pharmaceuticals firm Abbott India today reported 34.8 per cent decline in net profit to Rs 48.25 crore for the first quarter ended June 30, with sales hit by de-stocking in trade channels ahead of GST implementation.

Abbott India Q1 net profit down 35% at Rs 48 crore

2017-08-08 business-standard
Pharmaceuticals firm Abbott India today reported 34.8% decline in net profit to Rs 48.25 crore for the first quarter ended June 30, with sales hit by de-stocking in trade channels ahead of GST implementation. The company had posted the net profit of Rs 74.01 crore in the same quarter last financial year, Abbott India said in a BSE filing.

No more freebies: India plans crackdown on marketing by drugmakers

2017-08-02 in.reuters
MUMBAI (Reuters) - India, one of the world's largest markets for pharmaceuticals, is drawing up its first set of marketing rules for drugmakers, restricting gifts and trips offered to doctors and pharmacists to 1,000 rupees ($15), according to a draft proposal seen by Reuters.

No more freebies: India plans crackdown on marketing by drugmakers

2017-08-02 in.reuters
MUMBAI (Reuters) - India, one of the world's largest markets for pharmaceuticals, is drawing up its first set of marketing rules for drugmakers, restricting gifts and trips offered to doctors and pharmacists to 1,000 rupees ($15), according to a draft proposal seen by Reuters.

No more freebies: India plans crackdown on marketing by drugmakers

2017-08-02 moneycontrol
India, one of the world's largest markets for pharmaceuticals, is drawing up its first set of marketing rules for drugmakers, restricting gifts and trips offered to doctors and pharmacists to 1,000 rupees ($15), according to a draft proposal seen by Reuters.

Broker's Call

2017-05-23 thehindubusinessline
GlaxoSmithKline (GSK) started its journey in India in 1924 to become one of the leaders in the pharmaceutical industry with a rich healthcare heritage.